Also trades as: 2186.HK (HKSE) · $vol 10M

$0.27

+0.00 (+0.00%)

OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 43 · $1.1B mcap · 2.13B float · 0.0026% daily turnover · Short 100% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

Income Trends

Revenue

$6.1B -1.3% ▼

5Y CAGR: -0.9%

Gross Profit

$4.0B -3.8% ▼

5Y CAGR: -3.7%

Operating Income

$1.3B +25.5% ▲

5Y CAGR: -8.3%

Net Income

$472M -11.4% ▼

5Y CAGR: -20.3%

EPS (Diluted)

$0.02 -87.5% ▼

5Y CAGR: -48.0%

EBITDA

$2.2B +5.5% ▲

5Y CAGR: -1.6%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2020	FY2021	FY2022	FY2023	FY2024
Revenue	$5.5B	$5.2B	$6.0B	$6.1B	$6.1B
YoY Growth	-12.9%	-6.1%	+15.0%	+2.7%	-1.3%
Cost of Revenue	$1.5B	$1.8B	$1.8B	$1.9B	$2.0B
Gross Profit	$4.0B	$3.4B	$4.1B	$4.2B	$4.0B
Gross Margin	72.0%	65.3%	69.2%	68.4%	66.7%
R&D Expenses	$790M	$683M	$857M	$586M	$499M
SG&A Expenses	$2.2B	$2.3B	$2.4B	$2.7B	$2.4B
Operating Expenses	$2.8B	$3.1B	$3.2B	$3.2B	$2.8B
Operating Income	$1.4B	$387M	$1.2B	$1.0B	$1.3B
Operating Margin	25.6%	7.4%	20.3%	16.7%	21.3%
Interest Expense	$424M	$399M	$472M	$675M	$562M
Income Before Tax	$942M	-$75M	$670M	$700M	$839M
Tax Expense	$239M	$70M	$86M	$161M	$194M
Net Income	$707M	-$145M	$605M	$533M	$472M
Net Margin	12.8%	-2.8%	10.1%	8.7%	7.8%
EPS (Diluted)	$0.22	$-0.04	$0.17	$0.14	$0.02
EBITDA	$1.9B	$907M	$1.8B	$2.1B	$2.2B
Shares Outstanding	3.19B	3.45B	3.48B	3.73B	3.76B

Line Item	FY2022 Q4	FY2023 Q2	FY2023 Q4	FY2024 Q2	FY2024 Q4	FY2025 Q2	FY2025 Q4	FY2026 Q2
Revenue	$3.1B	$2.9B	$3.2B	$3.1B	$3.0B	$3.2B	$3.1B	$3.0B
Cost of Revenue	$1.0B	$961M	$978M	$996M	$1.0B	$1.0B	$1.1B	$1.1B
Gross Profit	$2.1B	$1.9B	$2.3B	$2.1B	$2.0B	$2.2B	$2.0B	$1.9B
Gross Margin	66.8%	66.9%	69.8%	67.6%	65.8%	67.8%	64.1%	63.4%
R&D Expenses	$431M	$295M	$291M	$281M	$218M	$193M	$217M	$253M
SG&A Expenses	$1.3B	$1.4B	$1.3B	$1.1B	$1.3B	$1.3B	$1.2B	$856M
Operating Expenses	$1.7B	$1.5B	$1.6B	$1.4B	$1.3B	$1.5B	$1.4B	$1.1B
Operating Income	$342M	$207M	$682M	$658M	$633M	$630M	$596M	$766M
Operating Margin	10.9%	7.1%	21.1%	21.4%	21.2%	19.8%	19.4%	25.9%
Interest Expense	$578M	$694M	$0	$0	$562M	$0	$342M	$300M
Income Before Tax	$294M	$229M	$471M	$530M	$309M	$458M	$479M	$508M
Tax Expense	$14M	$84M	$77M	$92M	$102M	$100M	$136M	$133M
Net Income	$308M	$150M	$383M	$388M	$84M	$313M	$301M	$385M
Net Margin	9.8%	5.2%	11.8%	12.6%	2.8%	9.8%	9.8%	13.0%
EPS (Diluted)	$0.09	$0.04	$0.10	$0.10	$-0.08	$0.08	$0.07	$0.10
EBITDA	$666M	$524M	$1.0B	$939M	$1.3B	$1.0B	$1.0B	$1.2B
Shares Outstanding	3.48B	3.69B	3.76B	3.76B	3.76B	3.76B	4.04B	3.99B

LYPHF OTC

Income Trends

Profit Margins

Year-over-Year Growth

Sign in to InsiderStreet